Nils-Olov Hermansson
AstraZeneca (Sweden)(SE)
Publications by Year
Research Areas
Receptor Mechanisms and Signaling, Computational Drug Discovery Methods, Pancreatic function and diabetes, Plant Stress Responses and Tolerance, T-cell and B-cell Immunology
Most-Cited Works
- → The orphan receptor GPR55 is a novel cannabinoid receptor(2007)1,550 cited
- → Structural insight into allosteric modulation of protease-activated receptor 2(2017)248 cited
- → CETSA beyond Soluble Targets: a Broad Application to Multipass Transmembrane Proteins(2019)91 cited
- → AZD8797 is an allosteric non-competitive modulator of the human CX3CR1 receptor(2015)56 cited
- → Leveraging a gain-of-function allele of Caenorhabditis elegans paqr-1 to elucidate membrane homeostasis by PAQR proteins(2020)18 cited
- → Adenosine is not a direct GHSR agonist – artificial cross‐talk between GHSR and adenosine receptor pathways(2007)13 cited
- → Identification of novel GPR81 agonist lead series for target biology evaluation(2020)11 cited
- → Comparing Flow Cytometry QBeads PlexScreen Assays with Other Immunoassays for Determining Multiple Analytes(2018)10 cited
- → Abstract 4357315: AZD0233: a CX3CR1 Modulator that Regulates Immune Cells, Improves Cardiac Function, and Alleviates Myocardial Fibrosis in a Mouse Model of Dilated Cardiomyopathy(2025)1 cited
- → Crystal structure of a thermostabilised human protease-activated receptor-2 (PAR2) in complex with AZ8838 at 2.8 angstrom resolution(2017)